Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1681
    +0.0024 (+0.21%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.14%)
     
  • Bitcoin GBP

    51,224.92
    -474.79 (-0.92%)
     
  • CMC Crypto 200

    1,330.33
    -66.21 (-4.74%)
     
  • S&P 500

    5,112.42
    +64.00 (+1.27%)
     
  • DOW

    38,316.20
    +230.40 (+0.60%)
     
  • CRUDE OIL

    83.85
    +0.28 (+0.34%)
     
  • GOLD FUTURES

    2,349.10
    +6.60 (+0.28%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

This Biotech Stock Rocketed On A $150 Million Deal With Celgene

This Biotech Stock Rocketed On A $150 Million Deal With Celgene

Prothena jumped by doubt digits late Tuesday on a $150 million deal with Celgene to develop treatments for neurodegenerative diseases.